The pharma giant announced the decision to change its name to GSK in an April 27 earnings release, but officially made the change May 16.
The company said the name change will soon be reflected in the London Stock Exchange and the New York Stock Exchange.
The switch to the three-letter acronym comes as the British drugmaker is working on a planned de-merger to spin out its consumer healthcare business by mid-2022.
In February, GSK announced its consumer healthcare arm would be called Haleon and will include brands such as Advil, Panadol, Excedrin, Centrum multivitamin and Tums.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
